Related Experiment Video
Updated: May 4, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
[Progress in immunotherapy for non-small cell lung cancer]
1Department of Respiratory Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.
Immunotherapy offers a promising new approach for treating advanced non-small cell lung cancer (NSCLC), showing potential to improve survival rates. This strategy harnesses the immune system to fight cancer, marking a significant shift in NSCLC treatment paradigms.
Area of Science:
- Oncology
- Immunology
Context:
- Advanced non-small cell lung cancer (NSCLC) has a historically poor five-year survival rate.
- Conventional treatments like surgery, chemotherapy, and radiation show limitations for advanced NSCLC.
- Recent breakthroughs in immunotherapy present a novel treatment avenue.
Purpose:
- To explore the role and advancements of immunotherapy in treating non-small cell lung cancer.
- To highlight the potential of novel immunotherapeutic agents in improving patient outcomes.
Summary:
- Immunotherapy utilizes the patient's immune system to combat cancer.
- Novel agents like tumor vaccines and checkpoint inhibitors are being evaluated.
- Some immunotherapies have demonstrated prolonged survival in clinical trials.
- Established immune-related response criteria aid in evaluating treatment efficacy.
Impact:
- Immunotherapy is poised to become a fundamental treatment strategy for NSCLC.
- This approach offers new hope for patients with advanced lung cancer.
- Further research and clinical application of immunotherapy are expected to improve NSCLC survival rates.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...